EXEL : Summary for Exelixis, Inc. - Yahoo Finance

We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets open in 1 hr 9 mins

Exelixis, Inc. (EXEL)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.61 -1.64 (-8.99%)
At close: 4:00 PM EST

16.65 0.04 ( 0.24% )
Pre-Market: 8:00 AM EST

People also watch :
ARRY ARIA IMGN CLDX SGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close 18.25
Open 0.00
Bid 16.75 x 900
Ask 17.15 x 600
Day's Range 16.42 - 17.94
52 Week Range 3.55 - 18.29
Volume 9,777,639
Avg. Volume 7,004,687
Market Cap 4.76B
Beta 2.44
PE Ratio (TTM) -25.24
EPS (TTM) -0.66
Earnings Date Feb 27, 2017 - Mar 3, 2017
Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 18.50
Trade prices are not sourced from all markets
  • This Dynamic Duo of Catalysts Sent Exelixis, Inc. Higher by 60% in November
    Motley Fool 3 days ago

    This Dynamic Duo of Catalysts Sent Exelixis, Inc. Higher by 60% in November

    Can the good times keep rolling for Exelixis and its lead cancer drug?

  • Hedge Funds Aren’t Crazy About John Bean Technologies Corp (JBT) Anymore
    Insider Monkey 3 days ago

    Hedge Funds Aren’t Crazy About John Bean Technologies Corp (JBT) Anymore

    We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks. Both the S&P 500 and Russell 2000 were up since the end of the second quarter, but small-cap stocks outperformed the large-cap stocks by double digits. This is important […]

  • Motley Fool 6 days ago

    Why Exelixis Was a Top Stock in 2016 So Far

    This cancer drugmaker is serving up tasty performance this holiday season.

  • 3 Biotech Stocks to Buy in December
    Motley Fool 6 days ago

    3 Biotech Stocks to Buy in December

    Looking for a good biotech stock to gift yourself this holiday season? Our contributors think you'll love these three.

  • Exelixis (EXEL): Strong Industry, Solid Earnings Estimate Revisions
    Zacks 7 days ago

    Exelixis (EXEL): Strong Industry, Solid Earnings Estimate Revisions

    Exelixis (EXEL) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.

  • 5 Stocks Up 100% or More This Year
    Motley Fool 8 days ago

    5 Stocks Up 100% or More This Year

    While the broad market has had a bullish run in 2016, it's nothing compared with these five companies that have doubled their stock price in 2016 alone.

  • Is Wright Medical Group Inc (WMGI) a Good Stock for Your Portfolio?
    Insider Monkey 8 days ago

    Is Wright Medical Group Inc (WMGI) a Good Stock for Your Portfolio?

    It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 7.6% over […]

  • What's Pfizer's Excuse for Not Buying Exelixis?
    Motley Fool 8 days ago

    What's Pfizer's Excuse for Not Buying Exelixis?

    One way Pfizer could sidestep a threat to its top-selling kidney cancer drug would be to acquire Exelixis lock, stock, and barrel, but buying it may not make sense for the pharmaceutical giant.

  • Hedge Funds Are Buying RealPage, Inc. (RP)
    Insider Monkey 8 days ago

    Hedge Funds Are Buying RealPage, Inc. (RP)

    The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentive to do the research necessary […]